| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 110.96B | 89.82B | 87.15B | 86.79B | 111.69B |
| Gross Profit | 110.96B | 89.82B | 87.15B | 86.79B | 99.03B |
| EBITDA | 0.00 | 10.59B | -738.00M | 7.29B | 10.05B |
| Net Income | 9.41B | 7.89B | 7.19B | 5.06B | 7.29B |
Balance Sheet | |||||
| Total Assets | 635.23B | 653.76B | 644.45B | 696.70B | 775.49B |
| Cash, Cash Equivalents and Short-Term Investments | 22.19B | 333.57B | 320.12B | 323.68B | 424.91B |
| Total Debt | 15.79B | 62.14B | 59.54B | 63.75B | 61.84B |
| Total Liabilities | 585.75B | 601.28B | 597.49B | 648.32B | 700.26B |
| Stockholders Equity | 47.18B | 49.94B | 49.58B | 46.07B | 71.13B |
Cash Flow | |||||
| Free Cash Flow | 20.22B | 11.99B | 6.01B | 7.53B | 6.18B |
| Operating Cash Flow | 20.64B | 12.47B | 6.44B | 7.88B | 6.53B |
| Investing Cash Flow | -10.21B | -11.25B | -1.59B | -155.00M | -8.95B |
| Financing Cash Flow | -7.80B | -7.33B | -4.34B | -6.12B | -4.33B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $37.46B | 10.99 | 22.01% | 1.55% | 6.90% | 41.67% | |
75 Outperform | $33.03B | ― | 21.07% | ― | 8.66% | ― | |
74 Outperform | $96.65B | 9.07 | 16.97% | 5.03% | 5.74% | 36.28% | |
73 Outperform | $21.59B | 11.69 | 13.53% | 3.44% | -23.49% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | $12.08B | 10.92 | 11.63% | 5.77% | 33.06% | 50.47% | |
62 Neutral | $39.59B | 15.62 | 7.50% | 2.02% | -19.92% | 7.41% |